Bela Peethambaran

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

International journal of molecular sciences

Exploration of targeted anti-tumor therapy

PloS one

University of the Sciences

Mississippi State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of the Sciences Aug 15 2010

United States

Associate Professor :: Biological Sciences

Education History

Mississippi State University

United States

PHD :: Biochemsitry and Molecular Biology

Publications

Vignesh Sivaganesh, Tram M Ta, Bela Peethambaran
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway. International journal of molecular sciences 25 (13) (2024)
Vignesh Sivaganesh, Tram M Ta, Bela Peethambaran
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway. International journal of molecular sciences 25 (13) (2024)
Vignesh Sivaganesh, Tram M Ta, Bela Peethambaran
Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway. International journal of molecular sciences 25 (13) (2024)
Vignesh Sivaganesh, Bela Peethambaran
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Vignesh Sivaganesh, Bela Peethambaran
Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer. Exploration of targeted anti-tumor therapy 4 (6) (2023)
Norman Fultang, Abhinav Illendula, Brian Chen, Chun Wu, Subash Jonnalagadda, Nathan Baird, Zachary Klase, Bela Peethambaran
Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity. PloS one 14 (5) (2019)

Bela Peethambaran.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Bela Peethambaran